Clinical Scorecard: Anxiety and Depression Following Stroke: Prevalence, Underlying Mechanisms, and Approaches to Management

At a Glance

Key Highlights

• Approximately one third of stroke patients develop depressive symptoms.
• Anxiety prevalence ranges from 20% to 30% among stroke survivors.
• Poststroke mood disorders significantly impact functional recovery and quality of life.
• Pharmacological interventions are essential for moderate to severe cases.
• Nonpharmacological interventions can enhance emotional well-being and neuroplasticity.
• Timely recognition and systematic screening for mood disorders are crucial.

Guideline-Based Recommendations

Diagnosis

• Timely recognition of poststroke mood disorders is crucial.
• Systematic screening for mood disorders during acute and subacute phases.

Management

• Use SSRIs and SNRIs for pharmacological treatment.
• Incorporate psychological therapies and structured rehabilitation.

Monitoring & Follow-up

• Individualized dosing and monitoring for adverse effects are essential.
• Assess suicidal ideation during mood screening.

Risks

• Increased rehospitalization and elevated mortality risk associated with untreated mood disorders.

Patient & Prescribing Data

Stroke survivors with anxiety and depression.

SSRIs and SNRIs improve mood and cognitive function; nonpharmacological approaches enhance adherence to rehabilitation.

Clinical Best Practices

• Integrate biological, psychological, and social factors in treatment plans.
• Utilize multimodal interventions for optimal recovery.
• Focus on high-quality randomized controlled trials for future research.
• Emphasize individualized interventions and monitoring for adverse effects.

References

• Global Burden of Disease Study
• Systematic Reviews on Poststroke Mood Disorders